Elevation Oncology, Inc. (ELEV) NASDAQ
0.37
-0.0079(-2.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Elevation Oncology, Inc.
Address
888 Seventh Avenue
Boston, NY 10106
United States of America (the)
Phone
716 371 1125
Sector
Healthcare
Industry
Biotechnology
Employees
34
First IPO Date
June 25, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Joseph J. Ferra Jr. | Chief Executive Officer, President & Director | 931,579 | 1975 |
| Valerie Malyvanh Jansen | Chief Medical Officer | 685,941 | 1979 |
| Tammy Furlong | Chief Financial Officer & Secretary | 0 | 1972 |
| Biren Shah | Senior Vice President of Business & Corporate Development | 0 | N/A |
| Robert C. Yang | Senior Vice President & General Counsel | 0 | N/A |
| Ryan Bloomer | Senior Vice President of Technical Operations | 0 | N/A |
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
